Donovan Comments on Merger of LHC Group, Almost Family
November 17, 2017
Modern Healthcare
Partner Christopher Donovan is quoted in a Modern Healthcare article, “LHC Group, Almost Family merger highlights growth of post-acute market,” which notes that many health systems are shedding their home health businesses and forming joint ventures with national for-profit operators.
Donovan said joint ventures have regulatory hurdles to clear in safe harbors, governance, credit and liquidity limits, but provide quicker access to market and avenues to alternative payment models. “Most providers will find that both acquisition and joint venture models work, but it is dependent on the market,” he said. “It’s important to deploy the correct strategy in the correct market.”
Donovan said joint ventures have regulatory hurdles to clear in safe harbors, governance, credit and liquidity limits, but provide quicker access to market and avenues to alternative payment models. “Most providers will find that both acquisition and joint venture models work, but it is dependent on the market,” he said. “It’s important to deploy the correct strategy in the correct market.”
People
Related News
July 28, 2025
In the News
Mark Wolfson Honored in Florida Bar Spotlight
Foley & Lardner LLP partner Mark Wolfson was featured by The Florida Bar for his contributions to the Florida legal community in a "Past Chair Spotlight."
July 24, 2025
In the News
Margaret Nelson Assesses SEC Enforcement Philosophy
Foley & Lardner LLP partner Margaret Gembala Nelson commented in the Private Equity Law Report article, "SEC Enforcement Action Raises Potential Materiality Threshold for Conflicts of Interest," sharing insight on enforcement philosophy at the U.S. Securities and Exchange Commission.
July 24, 2025
In the News
Foley's Trial Team Featured Following Landmark Victory in Texas Trade Secret Case
Foley & Lardner LLP’s recent landmark appellate victory in a Texas trade secrets case is featured in the Texas Lawyer article, "Ruling Sets Precedent for Employment, Trade Secrets, Fiduciary Duty."